XJPX4438
Market cap17mUSD
Dec 30, Last price
337.00JPY
1D
0.60%
1Q
-19.76%
IPO
-92.36%
Name
Welby Inc
Chart & Performance
P/E
—
P/S
4.85
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.71%
Rev. gr., 5y
-6.58%
Revenues
575m
-45.29%
Net income
-505m
L
CFO
-174m
L+52.48%
Profile
Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates Welby My Carte platform. The company was incorporated in 2011 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 575,000 -45.29% | 1,050,994 -7.74% | ||||||
Cost of revenue | 1,012,000 | 295,553 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (437,000) | 755,441 | ||||||
NOPBT Margin | 71.88% | |||||||
Operating Taxes | 2,000 | 4,241 | ||||||
Tax Rate | 0.56% | |||||||
NOPAT | (439,000) | 751,200 | ||||||
Net income | (505,000) -1,589.28% | 33,909 -125.95% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 1,000 | 7,140 | ||||||
Long-term debt | 1,210 | |||||||
Deferred revenue | ||||||||
Other long-term liabilities | 1,000 | (1,000) | ||||||
Net debt | (955,000) | (824,470) | ||||||
| Cash flow | ||||||||
Cash from operating activities | (174,000) | (114,112) | ||||||
CAPEX | (84,387) | (32,752) | ||||||
Cash from investing activities | 235,613 | (7,043) | ||||||
Cash from financing activities | (8,749) | (8,739) | ||||||
FCF | (196,657) | 583,075 | ||||||
| Balance | ||||||||
Cash | 883,000 | 830,820 | ||||||
Long term investments | 73,000 | 2,000 | ||||||
Excess cash | 927,250 | 780,270 | ||||||
Stockholders' equity | (119,520) | 360,932 | ||||||
Invested Capital | 1,238,520 | 892,541 | ||||||
ROIC | 83.97% | |||||||
ROCE | 60.27% | |||||||
| EV | ||||||||
Common stock shares outstanding | 7,833 | 7,839 | ||||||
Price | 667.00 83.24% | 364.00 -48.22% | ||||||
Market cap | 5,224,458 83.11% | 2,853,226 -48.18% | ||||||
EV | 4,296,458 | 2,028,756 | ||||||
EBITDA | (434,127) | 757,523 | ||||||
EV/EBITDA | 2.68 | |||||||
Interest | 20 | 53 | ||||||
Interest/NOPBT | 0.01% | |||||||